Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice

  • Julie C. Ullman
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Annie Arguello
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Jennifer A. Getz
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Akhil Bhalla
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Cathal S. Mahon
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Junhua Wang
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Tina Giese
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Catherine Bedard
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Do Jin Kim
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Jessica R. Blumenfeld
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Nicholas Liang
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Ritesh Ravi
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Alicia A. Nugent
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Sonnet S. Davis
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Connie Ha
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Joseph Duque
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Hai L. Tran
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Robert C. Wells
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Steve Lianoglou
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Vinay M. Daryani
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Wanda Kwan
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Hilda Solanoy
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Hoang Nguyen
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Timothy Earr
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Jason C. Dugas
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Michael D. Tuck
    Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA.
  • Jennifer L. Harvey
    Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA.
  • Michelle L. Reyzer
    Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA.
  • Richard M. Caprioli
    Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA.
  • Sejal Hall
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Suresh Poda
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Pascal E. Sanchez
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Mark S. Dennis
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Kannan Gunasekaran
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Ankita Srivastava
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Thomas Sandmann
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Kirk R. Henne
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Robert G. Thorne
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Gilbert Di Paolo
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Giuseppe Astarita
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Dolores Diaz
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Adam P. Silverman
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Ryan J. Watts
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Zachary K. Sweeney
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Mihalis S. Kariolis
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Anastasia G. Henry
    Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.

書誌事項

公開日
2020-05-27
DOI
  • 10.1126/scitranslmed.aay1163
公開者
American Association for the Advancement of Science (AAAS)

この論文をさがす

説明

<jats:p>An enzyme transport vehicle enables brain delivery of lysosomal enzymes across the blood-brain barrier in mice.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ